2020 mAbTalk symposium

Revisit the Perspectives of Bispecific Antibodies under the COVID-19 Pandemic

Dec. 5, 2020, 8 a.m. (US EDT) | Dec. 5, 2020, 9 p.m. (Beijing)

Live on Zoom, Free for Everyone

Login to view recordings

Overview

Chinese Antibody Society invites you to join our 2020 mAbTalk virtual symposium, “Revisiting the Perspectives on Bispecific Antibodies under the COVID-19 Pandemic", on Dec 5th, 2020.

Bispecific and multispecific antibody-based therapies are at the cutting-edge of therapeutic biologics development, and provide new opportunities to address unmet medical needs. In our one-day symposium, eight speakers from both industry and academia will share insights on all aspects of bispecific antibody-based therapeutic development, including novel targets and molecular formats, development of the lead candidate from discovery to clinics, CMC challenges and strategies, regulatory considerations, patent protection strategies, and COVID-19 related therapeutics. Online LIVE Q & A sessions will be included after every presentation.

We sincerely hope you can join us online on December 5th (US EST) to enjoy the state-of-the-art science and direct communication with experts in the field.

Sponsors

title sponsor

sponsor

Speakers

Hover above speaker cards to read bio

bio

Kedan Lin, PhD

VP, Innovent Biologics

bio

Mitchell Ho, PhD

Sr. Investigator, LMB, NCI

bio

Audrey Jia, MD, PhD

Principal Consultant, DataRevive

bio

Ting Xu, PhD

Founder/CEO, Alphamab Oncology

bio

Yue Liu, PhD

Founder/CEO, Ab Studio and Ab Therapeutics

bio

Paul Parren, PhD

Executive VP, Lava Therapeutics

bio

Teresa Lavoie, PhD

Principal, Fish & Richardson

bio

Jizu Yi, PhD

SVP, YZY Biopharma

bio

David Ho, MD

Director, AIDS Center, Columbia Univ.

bio

Jijie Gu, PhD

CSO/EVP, WuXi Biologics

Agenda

Starts at 12/05/2020 8 a.m. (US EDT) | 12/05/2020 9 p.m. (Beijing)

Hover to view abstract

12/05/2020 8 a.m. EDT

Chairperson's Remarks

Mitchell Ho, PhD, Sr. Investigator, LMB, NCI

12/05/2020 8:05 a.m. EDT

Next Wave of Innovation of Drug Discovery Driven by Antibody-based Multispecific and Functional Drugs

Jijie Gu, PhD, CSO/EVP, WuXi Biologics

12/05/2020 8:45 a.m. EDT

Development of KN046 - a PD-L1/CTLA-4 BsAb

Ting Xu, PhD, Founder/CEO, Alphamab Oncology

12/05/2020 9:15 a.m. EDT

CMC Challenges and Strategies for Bispecific Antibody Development

Jizu Yi, PhD, SVP, YZY Biopharma

12/05/2020 9:45 a.m. EDT

Bispecific γδ-T cell Engagers for Cancer Immunotherapy.

Paul Parren, PhD, Executive VP, Lava Therapeutics

12/05/2020 10:15 a.m. EDT

Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike.

David Ho, MD, Director, AIDS Center, Columbia Univ.

12/05/2020 10:45 a.m. EDT

Regulatory Challenges and opportunities for biological products

Audrey Jia, MD, PhD, Principal Consultant, DataRevive

12/05/2020 11:15 a.m. EDT

break

CAS Staff, , The Chinese Antibody Society

12/05/2020 12:45 p.m. EDT

Patent Protection Strategies for Bispecific Antibodies

Teresa Lavoie, PhD, Principal, Fish & Richardson

12/05/2020 1:15 p.m. EDT

Combining Computer Aided Design and Traditional Antibody Discovery and Engineering Technologies to Develop Multi-Specific Antibodies

Yue Liu, PhD, Founder/CEO, Ab Studio and Ab Therapeutics

FAQ of Meeting Registration

If you have any questions, feel free to reach out to us
Yes! It's free for both CAS members and non-members
Follow these simple steps to register and connect:
1. Click on the registration button at the top of the page, then answer a few simple questions to register
2. You will a receive a invitation link in the email that you can use to connect to the event
3. Before the event starts, download the Goto Webinar app (Mac, Windows, mobile phone compatible) here
4. Click on the invitation link in your email to join the meeting
Yes! GotoWebinar is available for users outside of U.S., including China and Europe
We will be hosting a WeChat group for all attendees.
If you have joined our the WeChat group for attendees, the easiest way to get a response is to post your question there. Otherwise, send us an email at conference@chineseantibody.org
This web app is a Python Django project independently coded (frontend+backend+deployment on AWS) by Xin Yu (Github, LinkedIn) in her volunteer capacity at the Chinese Antibody Society. Contents are maintained by CAS IT team. If you're interested in participating in the future development of this web app, please submit a volunteer application and request an interview with the IT team. We require a minimum of 2 years experience as a Django developer. © Chinese Antibody Society 2021. All Rights Reserved. Legal Disclaimer
Icon